Join over 200 academics and industry professionals in Edinburgh on 18th and 19th May

Come and explore the latest insights covering three areas of technology for drug target validation:

• Application of Precise Genome Editing for Target Validation
• Target Engagement and Deconvolution
• Imaging Techniques and their application to Drug Discovery Screening
• Expand your knowledge and advance your career

Come and discuss the latest advancements in Cutting-edge Technologies for Drug Target Validation with world-leading academics and industry professionals.

This conference is co-organised by The Society for Laboratory Automation and Screening (SLAS) and SULSA.

View the programme here

Speakers

• Chas Bountra – Chief Scientist – The Structural Genomics Consortium, University of Oxford
• Christian Eggeling – Professor of Molecular Immunology – University of Oxford
• Paul French – Professor of Physics – Imperial College London
• Lars Hammarström – Senior Researcher – Karolinska Institutet
• Kilian Huber – CeMM Research Center for Molecular Medicine – Senior Postdoctoral Fellow
• William Janzen – Executive Director – Epizyme
• Andreas Leibbrandt – Head of Haplobank – IMBA – Institute of Molecular Biotechnology GmbH
• Lorenz Mayr – Vice President, Reagents & Assay Development – AstraZeneca
• Nicola McCarthy – Oncology Program Manager – Horizon Discovery
• Saskia Otto – Bayer Health Care
• Mary Phillips-Jones – Senior Lecturer – University of Central Lancashire
• Steven Pollard – MRC Centre for Regenerative Medicine – University of Edinburgh
• Friedrich Reinhard – Project Manager Science & Technology – Cellzome, GlaxoSmithKline
• Nathan Ross – Investigator III – Developmental and Molecular Pathways – Novartis
• William Skarnes – Senior Group Leader – Wellcome Trust Sanger Institute
• Jonathan Wingfield – Team Leader – AstraZeneca
• John Wiseman – Associate Principal Scientist – Discovery Sciences, Transgenics – AstraZeneca

Session chairs

• Manfred Auer – SULSA Chair of Translational Biology – University of Edinburgh
• Neil Carragher – Principal Investigator Drug Discovery – IGMM, University of Edinburgh
• Steve Rees – Vice President Screening Sciences & Sample Management – AstraZeneca

View more information here